Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 11, 2017 - Issue
Submit an article Journal homepage
74
Views
12
CrossRef citations to date
0
Altmetric
Review

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma

Pranabashis HaldarRespiratory Biomedical Research Unit, Glenfield Hospital, University of Leicester, Leicester, UKCorrespondence[email protected]
Pages 81-95 | Published online: 27 Jun 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Martina Votto, Maria De Filippo, Amelia Licari, Alessia Marseglia, Mara De Amici & Gian Luigi Marseglia. (2021) Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review. Biologics: Targets and Therapy 15, pages 133-142.
Read now
Jaymin B Morjaria, Rosalia Emma, Virginia Fuochi, Riccardo Polosa & Massimo Caruso. (2019) An evaluation of mepolizumab for the treatment of severe asthma. Expert Opinion on Biological Therapy 19:6, pages 491-500.
Read now
Corrado Pelaia, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Rosa Terracciano, Rocco Savino & Girolamo Pelaia. (2017) Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab. Drug Design, Development and Therapy 11, pages 3137-3144.
Read now

Articles from other publishers (9)

Nicola Ullmann, Francesca Peri, Olivia Florio, Federica Porcaro, Elisa Profeti, Alessandro Onofri & Renato Cutrera. (2022) Severe Pediatric Asthma Therapy: Mepolizumab. Frontiers in Pediatrics 10.
Crossref
Maruša Kopač Šokić, Matija Rijavec, Peter Korošec, Urška Bidovec-Stojkovič, Izidor Kern, Romana Vantur & Sabina Škrgat. (2022) Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients. Journal of Personalized Medicine 12:1, pages 70.
Crossref
Markus A. Rose. (2021) Biologika beim schweren/schwierigen Asthma bronchiale im Kindes- und JugendalterBiologicals for severe/difficult bronchial asthma in childhood and adolescence. Der Pneumologe 18:6, pages 395-404.
Crossref
Daniele Russo, Paola Di Filippo, Marina Attanasi, Mauro Lizzi, Sabrina Di Pillo & Francesco Chiarelli. (2021) Biologic Therapy and Severe Asthma in Children. Biomedicines 9:7, pages 760.
Crossref
Amelia Licari, Sara Manti, Alessia Marseglia, Maria De Filippo, Elisabetta De Sando, Thomas Foiadelli & Gian Luigi Marseglia. (2020) Biologics in Children with Allergic Diseases. Current Pediatric Reviews 16:2, pages 140-147.
Crossref
Riccardo Castagnoli, Alessia Marseglia, Ilaria Brambilla, Gian Luigi Marseglia & Amelia Licari. (2020) Severe uncontrolled asthma in children: practical approach on diagnosis and management. Minerva Pediatrica 72:3.
Crossref
Corrado Pelaia, Giovanni Paoletti, Francesca Puggioni, Francesca Racca, Girolamo Pelaia, Giorgio Walter Canonica & Enrico Heffler. (2019) Interleukin-5 in the Pathophysiology of Severe Asthma. Frontiers in Physiology 10.
Crossref
Virginija Kalinauskaite-Zukauske, Andrius Januskevicius, Ieva Janulaityte, Skaidrius Miliauskas & Kestutis Malakauskas. (2019) Serum Levels of Epithelial-Derived Cytokines as Interleukin-25 and Thymic Stromal Lymphopoietin after a Single Dose of Mepolizumab in Patients with Severe Non-Allergic Eosinophilic Asthma: A Short Report. Canadian Respiratory Journal 2019, pages 1-7.
Crossref
Nora Drick, Benjamin Seeliger, Tobias Welte, Jan Fuge & Hendrik Suhling. (2018) Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment response. BMC Pulmonary Medicine 18:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.